House bill HR7640-117
Energy and Commerce Committee
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").
• Last activity on May 03, 2022
• Introduced May 03, 2022
• By Rep. Bilirakis, Gus M. [R-FL-12]